REVRQ · Revlon Inc /De/ - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $1.98B | $2.08B | $1.90B | $2.42B | $2.69B | $2.33B |
| Cost of Revenue | $835.70M | $849.10M | $860.50M | $1.05B | - | - |
| Gross Profit | $1.14B | $1.23B | $1.04B | $1.37B | $1.54B | $1.42B |
| R&D | $30.10M | $32.50M | $29.30M | $40.30M | $35.70M | $37.00M |
| SG&A | $1.03B | $1.10B | $1.07B | $1.32B | $1.47B | $1.16B |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $105.70M | $125.70M | $143.30M | $162.90M | $155.80M | $123.20M |
| Operating Income | $79.90M | $103.20M | ($226.30M) | $60.70M | ($22.30M) | $155.30M |
| Interest Expense | - | - | - | $176.60M | $149.80M | $105.20M |
| Income Tax | $31.70M | $6.20M | $158.80M | $200.0K | $21.80M | $25.50M |
| Net Income | ($673.90M) | ($206.90M) | ($619.00M) | ($157.70M) | ($183.20M) | ($21.90M) |
| EPS - Basic | ($12.28) | ($11.59) | - | - | ($3.48) | ($0.42) |
| EPS - Diluted | ($12.28) | ($11.59) | - | - | ($3.48) | ($0.42) |
Balance Sheet
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $249.30M | $102.40M | $97.10M | $104.30M | $87.10M | $186.80M |
| Accounts Receivable | $352.70M | $383.80M | $352.30M | $423.40M | $444.80M | $423.90M |
| Inventory | $469.30M | $417.40M | $462.60M | $448.40M | $497.90M | $424.60M |
| Accounts Payable | $125.90M | $217.70M | $203.30M | $251.80M | $336.90M | $296.90M |
| Current Assets | $1.21B | $1.04B | $1.05B | $1.11B | $1.14B | $1.12B |
| Total Assets | $2.49B | $2.43B | $2.53B | $2.98B | $3.06B | $3.02B |
| Current Liabilities | $1.26B | $787.60M | $844.20M | $956.90M | $932.30M | $708.70M |
| Long-term Debt | $100.0K | $3.31B | $3.10B | $2.91B | $2.65B | $2.66B |
| Total Liabilities | - | - | - | - | - | - |
| Stockholders' Equity | ($2.66B) | ($2.01B) | ($1.86B) | ($1.22B) | ($770.40M) | ($614.80M) |
| Retained Earnings | ($3.51B) | ($2.84B) | ($2.63B) | ($2.01B) | ($1.56B) | ($1.38B) |
Cash Flow
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($243.50M) | ($11.00M) | ($97.30M) | ($68.30M) | ($139.30M) | $116.90M |
| Investing Cash Flow | ($13.80M) | ($12.10M) | ($10.30M) | $2.10M | ($108.30M) | ($1.09B) |
| Financing Cash Flow | $392.30M | $44.20M | $102.50M | $84.30M | $136.90M | $833.10M |
| CapEx | $13.80M | $14.20M | $10.30M | $29.00M | $108.30M | $59.30M |
| Free Cash Flow | ($257.30M) | ($25.20M) | ($107.60M) | ($97.30M) | ($247.60M) | $57.60M |
Ratios
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.8% | 59.2% | 54.8% | 56.5% | 57.3% | 60.7% |
| Operating margin | 4.0% | 5.0% | -11.9% | 2.5% | -0.8% | 6.7% |
| EBITDA margin | 9.4% | 11.0% | -4.4% | 9.2% | 5.0% | 11.9% |
| Net margin | -34.0% | -10.0% | -32.5% | -6.5% | -6.8% | -0.9% |
| Free cash flow margin | -13.0% | -1.2% | -5.7% | -4.0% | -9.2% | 2.5% |
| FCF / Net income | 0.38 | 0.12 | 0.17 | 0.62 | 1.35 | -2.63 |
| R&D / Revenue | 1.5% | 1.6% | 1.5% | 1.7% | 1.3% | 1.6% |
| SG&A / Revenue | 52.2% | 52.9% | 56.3% | 54.4% | 54.5% | 49.7% |
| Effective tax rate | - | - | - | - | - | 708.3% |
| Return on assets | -27.1% | -8.5% | -24.5% | -5.3% | -6.0% | -0.7% |
| Return on equity | 25.3% | 10.3% | 33.2% | 12.9% | 23.8% | 3.6% |
| Return on invested capital | - | 6.3% | -14.4% | 2.8% | -0.9% | 3.8% |
| Liquidity | ||||||
| Current ratio | 0.96 | 1.32 | 1.24 | 1.16 | 1.23 | 1.59 |
| Quick ratio | 0.59 | 0.79 | 0.69 | 0.69 | 0.69 | 0.99 |
| Cash ratio | 0.20 | 0.13 | 0.12 | 0.11 | 0.09 | 0.26 |
| Leverage | ||||||
| Debt / Equity | -0.00 | -1.64 | -1.67 | -2.38 | -3.44 | -4.33 |
| Debt / Assets | 0.00 | 1.36 | 1.23 | 0.98 | 0.87 | 0.88 |
| Debt / EBITDA | 0.00 | 14.44 | - | 13.00 | 19.88 | 9.56 |
| Interest coverage | - | - | - | 0.3x | -0.1x | 1.5x |
| Equity multiplier | -0.94 | -1.21 | -1.36 | -2.44 | -3.97 | -4.92 |
| Liabilities / Assets | - | - | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | 0.80 | 0.85 | 0.75 | 0.81 | 0.88 | 0.77 |
| Inventory turnover | 1.78 | 2.03 | 1.86 | 2.35 | - | - |
| Days sales outstanding | 65d | 67d | 68d | 64d | 60d | 66d |
| Days inventory outstanding | 205d | 179d | 196d | 156d | - | - |
| Days payable outstanding | 55d | 94d | 86d | 87d | - | - |
| Cash conversion cycle | 215d | 153d | 178d | 132d | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | -4.7% | 9.2% | -21.3% | - | 15.4% | 21.9% |
| Revenue CAGR (3y) | -6.5% | - | -10.9% | 1.2% | 11.5% | 16.0% |
| Revenue CAGR (5y) | -6.0% | -2.3% | -0.1% | 4.5% | 13.6% | 11.1% |
| Gross profit growth (YoY) | -6.9% | 17.8% | -23.7% | - | 8.9% | 13.7% |
| Operating income growth (YoY) | -22.6% | - | - | - | - | -28.0% |
| Net income growth (YoY) | -225.7% | 66.6% | -292.5% | - | -736.5% | - |
| EPS growth (YoY) | -6.0% | - | - | - | -728.6% | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | -921.0% | 76.6% | -10.6% | - | - | -46.2% |
| FCF CAGR (5y) | - | - | - | - | - | -9.4% |
| Book value growth (YoY) | -32.2% | -8.2% | -52.5% | - | -25.3% | -4.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Business segments
$2.08B totalRevlon Segment$727.90M · 35.0%
Elizabeth Arden Segment$532.30M · 25.6%
Portfolio Segment$419.10M · 20.2%
Fragrances Segment$399.40M · 19.2%
Product / service
$2.08B totalFragrances Segment$580.10M · 27.9%
Color Cosmetics$526.80M · 25.3%
Haircare$472.10M · 22.7%
Skin Care$333.30M · 16.0%
Beauty Care$166.40M · 8.0%
Geographic
$727.90M totalNorth America$389.40M · 53.5%
EMEA$170.60M · 23.4%
Pacific$70.50M · 9.7%
Latin America$57.30M · 7.9%
Asia$40.10M · 5.5%
Stability scores
Piotroski F-score
FY 2022 · 9-point quality
2/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations
Comparing REVLON INC /DE/ against the 5 most active filers in the same SIC group.